-Reuters
Sunshine Biopharma, Inc. Announces Pricing Of $10M Underwritten Public Offering
Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced the